Table 3.

Pupil size (PS) in millimeter at baseline and after (30 and 180 min) application with dorzolamide, latanoprost, and timolol.

	Mean (mm) ± SD			p-Value
	Baseline	30 min	180 min	Baseline vs. after
Prior to light
Dorzolamide	7.91 ± 0.72	7.82 ± 0.74	7.66 ± 0.71b	0.0004
Latanoprost	7.87 ± 0.65	7.87 ± 0.66	7.89 ± 0.65a	0.808
Timolol	7.92 ± 0.70	7.83 ± 0.76	7.79 ± 0.68b	0.026
Control	7.83 ± 0.70	7.78 ± 0.70	7.76 ± 0.71	0.138
p-Value	0.104	0.247	<0.0001

Control refers to a visit, where no drugs were applied.

Results are presented as mean ± SD. p-Value < 0.05 indicates the overall significant change.

^aSignificant difference between the specific drug and control measurement.

^bSignificant difference between measurement at baseline and after medication.